What is Pacira BioSciences, Inc.'s other — due after year three?

Pacira BioSciences, Inc. (PCRX) reported other — due after year three of $500K in Q4 2025.

What does other — due after year three mean?

Represents the portion of contractual purchase obligations within the 'Other' business segment that are due to be paid beyond the three-year horizon. This metric captures the long-term tail of the company's contractual commitments, providing insight into the stability and duration of its vendor or supply chain agreements. It is a key indicator of the company's long-term financial planning and potential future liability exposure.

Pacira BioSciences, Inc. PCRX Other — Due after year three

Similar metrics at other companies

CBTOther — Recorded Unconditional Purchase Obligation Due In Third Year

$4M—

CBTOther — Recorded Unconditional Purchase Obligation Due In Fourth Year

$2M—

CBTOther — Recorded Unconditional Purchase Obligation Due In Fifth Year

$1M—

CBTOther — Recorded Unconditional Purchase Obligation Due After Fifth Year

$1M—

CBTOther — Recorded Unconditional Purchase Obligation Due In Second Year

$9M—

LBTYBOther — Thereafter

$0—

Other financials

Income statement

See full

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

See full

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

See full

Market cap$958.91M-14.5%

Enterprise value$1.23B+2.6%

P/E186.6×—

P/S1.3×-0.3×

Profitability

See full

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

See full

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept pcrx:PurchaseObligationToBePaidAfterYearThree.

The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s other — due after year three.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s other — due after year three?: Pacira BioSciences, Inc. (PCRX) reported other — due after year three of $500K in Q4 2025.
What does other — due after year three mean?: Represents the portion of contractual purchase obligations within the 'Other' business segment that are due to be paid beyond the three-year horizon. This metric captures the long-term tail of the company's contractual commitments, providing insight into the stability and duration of its vendor or supply chain agreements. It is a key indicator of the company's long-term financial planning and potential future liability exposure.